|
× |
 |
Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics PDF |
$40.00 |
|
$40.00 |
|
× |
|
Comparative Effects of 30 Antipsychotics on Risk of Catatonia: An Analysis of the WHO Pharmacovigilance Database PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Multisite Study of Initial Respiration Rate and Heart Rate as Predictors of Posttraumatic Stress Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Omega-3 Polyunsaturated Fatty Acid (PUFA) Status in Major Depressive Disorder With Comorbid Anxiety Disorders PDF |
$40.00 |
|
$40.00 |
|
× |
|
What Happens With Adverse Events During 6 Months of Treatment With Selective Serotonin Reuptake Inhibitors? PDF |
$40.00 |
|
$40.00 |
|
× |
|
Effects of Dextroamphetamine on Depression and Fatigue in Men With HIV: A Double-Blind, Placebo-Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Clinical Trial of a Psychoeducation Group Intervention for Patients With Borderline Personality Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Exaggerated Acquisition and Resistance to Extinction of Avoidance Behavior in Treated Heroin-Dependent Men PDF |
$40.00 |
|
$40.00 |
|
× |
|
Successful Use of Electroconvulsive Therapy in the Setting of Multiple Risk Factors for Retinal Detachment PDF |
$40.00 |
|
$40.00 |
|
× |
|
Electroconvulsive Therapy Device Classification: Response to FDA Advisory Panel Hearing and Recommendations PDF |
$40.00 |
|
$40.00 |
|
× |
|
Regulatory and Scientific Issues in Studies to Evaluate Sexual Dysfunction in Antidepressant Drug Trials PDF |
$40.00 |
|
$40.00 |
|
|
